Cardiology
From the Journals
More evidence salt substitutes lower risk of CVD and death
The blood pressure–lowering effects of dietary salt substitutes have a clear protective effect on hard clinical outcomes, leading to a reduction...
From the Journals
Cardiorespiratory fitness key to longevity for all?
Risk for all-cause death was four times greater for U.S. veterans with lowest vs. those with highest cardiorespiratory fitness levels, regardless...
From the Journals
CV admissions on the rise in Americans with cancer
“I would say that this increase in cardiovascular admissions, that’s a failure from a preventative perspective.”
From the Journals
Concerns that low LDL-C alters cognitive function challenged in novel analysis
A Mendelian randomization study appears to exonerate very low LDL-C but not therapies from altering cognition.
From the Journals
Social isolation, loneliness tied to death, MI, stroke: AHA
Decades of research have clearly shown that social isolation and loneliness carry cardiovascular risks, a new American Heart Association...
From the Journals
Hot weather risk for nonfatal MI hinted for antiplatelets, beta-blockers
Why taking either drug class would promote nonfatal MIs on high-temperature days, or why it may have appeared that way, isn’t clear, but...
From the Journals
Onset and awareness of hypertension varies by race, ethnicity
Black, Hispanic, and Asian adults are more likely than Whites to be unaware of their high blood pressure.
News from the FDA/CDC
Long COVID doubles risk of some serious outcomes in children, teens
“Many of these conditions were rare or uncommon among children in this analysis, but even a small increase in these conditions is notable.”
From the Journals
‘Staggering’ CVD rise projected in U.S., especially in minorities
The estimated increases for 2025-2060 reflect a changing demographic landscape and are a call to action, say observers.
From the Journals
Gout flares linked to transient jump in MI, stroke risk
Causation is plausible, even suspected, say experts, who urge aggressive CV risk-factor management in gout patients and perhaps more willingness...
From the Journals
Ezetimibe plus statin: Attractive bypass to high-dose monotherapy
Early initiation of this approach should be considered in patients with challenging lipid disorders who are at increased risk of atherosclerotic...